Research Updates: alzheimer's and dementia

Below are short extracts from research updates about this subject - select more to read each item.

  1. Issue 291

    SAYYAHI and COLLEAGUES, Golestan University of Medical Sciences, Iran aimed to examine the chronic administration effect of vitamin E against scopolamine-induced memory loss and the number of M1 muscarinic receptor-ir neurons of the hippocampus in m1


  2. Issue 290

    NOLAN and COLLEAGUES, 1 Nutrition Research Centre Ireland, School of Health Science, Carriganore House, Waterford Institute of Technology, West Campus, Waterford, Ireland; 2 Age-related Care Unit, University Hospital Waterford, Waterford, Ireland; 31


  3. Issue 285

    AJITH,  1 Department of Biochemistry, Amala Institute of Medical Sciences, Amala Nagar, Thrissur-680 555, Kerala, India reviews recent updates regarding the roles of  ω -3 fatty acids in Alzheimer's Disease –AD.


  4. Issue 270

    LIN and COLLEAGUES, 1. Ningbo Key Laboratory of Behavioral Neuroscience, Zhejiang Provincial Key Laboratory of Pathophysiology, School of Medicine, Ningbo University, Ningbo 315211, China; 2. Li Dak Sum Yip Yio Chin Kenneth Li Marine Biopharmaceutic1


  5. Issue 265

    FINLEY and COLLEAGUES,  1. Adjunct Professor, Department of Nutrition and Food Science, 111 Food Science Building, Louisiana State University , Baton Rouge, Louisiana 70803, United States;  14719 Secret Harbor Place, Bradenton, Florida 3421


  6. Issue 254

    FARINA and COLLEAGUES, 1. Centre for Dementia Studies, Brighton and Sussex Medical School, Brighton, UK, BN1 9QH; 2. Medical School, University of Exeter, Exeter, UK, +44 (0) 1392 726018; 3. Old Age Psychiatry, Sussex Partnership NHS Foundation Trus1


  7. Issue 251

    ZENG and COLLEAGUES, 1. Children's Nutrition Research Center, Ministry of Education Key Laboratory of Child Development and Disorders, China International Science and Technology Cooperation Base for Child Development and Critical Disorders, Children1


  8. Issue 248

    LANZA and COLLEAGUES, 1 Oasi Research Institute - IRCCS, Troina, Italy. Electronic address: ; 2. School of Human and Social Science, University "Kore" of Enna, Enna, Italy; 3. Centro diurno Al1


  9. Issue 246

    SCHRAG and COLLEAGUES, (1)Department of Neurology, Yale University, New Haven, CT, USA. conducted a review to systematically analyze available data describing markers 1


  10. Issue 241

    SHINTO and COLLEAGUES,  (1)Department of Neurology, Oregon Health & Science University, Portland, OR, USA conducted a pilot study to evaluate the effects of supplementation with omega-3 fatty acids alone (ω-3) or omega-3 plus alpha li1


  11. Issue 241

    MANGIALASCHE and COLLEAGUES,  (1)Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Stockholm, Sweden; Institute of Gerontology a1


  12. Issue 237

    CEDERHOLM and COLLEAGUES, (1)Clinical Nutrition and Metabolism, Uppsala University, and Department of Geriatric Medicine, Uppsala University Hospital, Sweden review the literature regarding the potential role of omega-3 fatty acids to modulate cogni1


  13. Issue 235

    DYSKEN and COLLEAGUES,  (1)Minneapolis VA Health Care System, Minneapolis, Minnesota; (2)James J. Peters VA Medical Research Center, New York, New York; (3)William S. Middleton Memorial Veterans Hospital, Madison, Wisconsin; (4)Cooperative Stud1


  14. Issue 227

    Levi and Colleagues, Department of Neurobiology, Caring Sciences and Society, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden conducted a double-blind, placebo-controlled randomized OmegAD study to investigate wheth1


  15. Issue 225

    GIAVAROTTI and COLLEAGUES, (1)Instituto de Química, USP, Cidade Universitária, Avenida Lineu Prestes 748, 05508-900 São Paulo, SP, Brazil; (2)Instituto de Ciências Ambientais, Qu&iac1


  16. Issue 221

    ZAO and COLLEAGUES,  From the Department of Neurology, Huashan Hospital, Fudan University, Shanghai 200032, China performed a drug screen for compounds which modulate Apolipoprotein E (apoE), the brain&rs1


  17. Issue 220

    ZENG and COLLEAGUES, (1)Neurodegenerative Disease Research Group, Institute of Pharmaceutical Science, School of Biomedical Sciences, King's College London, London, United Kingdom. review recent1


  18. Issue 217

    MATHEW and SUBRAMANIAN, Department of Neurochemistry, National Institute of Mental Health & Neurosciences, Bangalore, Karnataka, India evaluated the antioxidant activity, cholinesterase inhibition, anti-amyloidogenic potential and neuroprotectiv1


  19. Issue 199

    SCHIPPER, Centre for Neurotranslational Research and Bloomfield Centre for Research in Aging, Lady Davis Institute for Medical Research, Jewish General Hospital, 3755 Cote St. Catherine Road, McGill University, Montreal, Quebec, Canada 1


  20. Issue 183

    KHALSA and COLLEAGUES, Alzheimer's Research and Prevention Foundation, Tucson, Arizona, USA examined changes in brain physiology during a chanting meditation practice using cerebral blood flow single-photon emission computed tomography.


« Prev 1 2

ICAN 2024 Skyscraper

Scientific and Medical Network 2

Cycle Around the World for Charity 2023

Climb Mount Kilimanjaro Charity 2023

top of the page